Reuters
13 Jul 2026, 02:37 UTC · 1h ago
China Medical System to pay Insilico up to $177 million for nervous system work
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Reuters
13 Jul 2026, 02:37 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
China Medical System has entered an agreement to pay Insilico Medicine up to 1.2 billion yuan ($177 million) in milestone payments for CNS disease R&D. — Significant milestone-based funding validates Insilico's drug discovery platform and provides a substantial potential revenue stream.
+0.60Which stocks this story touches
Entering a strategic R&D programme for CNS diseases represents investment in future pipeline growth.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
13h ago
